OptimizeRx (OPRX) said Tuesday that it has appointed Ed Stelmakh as chief financial and strategic officer, evolving from his previous responsibilities as its chief financial officer and chief operations officer.
The company said Brendan Merrell has been appointed COO from his prior role as senior vice president, client strategy and program management.
OptimizeRx said it has appointed Andy D'Silva as chief business officer, and Marion Odence-Ford as chief legal and administrative officer.
In addition, OptimizeRx said Theresa Greco, as chief commercial officer, will continue the oversight of the commercial team.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.